Safety evaluation of intravenous infusion port with complete implantation of internal jugular vein in children assisted by ultrasound in general anesthesia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032363

Enrollment

Unknown

Registered

2020-04-26

Start date

2020-04-24

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

A:0.5% ropivacaine 8mg

B:0.5% ropivacaine 10mg

C:0.5% ropivacaine 12mg

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing cesarean section and combined spinal and epidural anesthesia. 2. Patients aged 20 to 45 years;

Exclusion criteria

Exclusion criteria: 1. Patients with long-term (>=10 years) hypertension, diabetes mellitus, cardiac insufficiency (NYHA > grade 2) and renal insufficiency (GFR < 60ml / min); 2. Patients allergic to ropivacaine.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;Blood oxygen;Anesthesia block plane;Time to reach anesthesia block plane;Postoperative adverse reactions;	—

Secondary

Measure	Time frame
Lidocaine dosage;Ephedrine dosage;Apgar score of 1 min newborn;Apgar score of 5 min newborn;Anesthetic effect;	—

Countries

China

Contacts

Public ContactLiting Kuang

The First Affiliated Hospital of Sun Yat sen University

samk2002@qq.com+86 13560365048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026